n-benzyloxycarbonylprolylprolinal has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benoist, A; De Nanteuil, G; Hervé, Y; Lepagnol, J; Portevin, B; Rémond, G; Vincent, M | 1 |
| Andrisano, V; Cahlikova, L; Hostalkova, A; Hulcova, D; Jun, D; Korabecny, J; Kucera, T; Kunes, J; Marikova, J; Novakova, L; Opletal, L; Perez, DI; Siatka, T | 1 |
2 other study(ies) available for n-benzyloxycarbonylprolylprolinal and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives.
Topics: Alzheimer Disease; Amino Acid Sequence; Amnesia; Animals; Avoidance Learning; Bridged Bicyclo Compounds, Heterocyclic; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Sequence Data; Nerve Tissue Proteins; Prolyl Oligopeptidases; Pyrroles; Rats; Scopolamine; Serine Endopeptidases; Serine Proteinase Inhibitors; Structure-Activity Relationship | 1996 |
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Berberis; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Isoquinolines; Magnetic Resonance Spectroscopy; Plant Exudates | 2019 |